在体内突变发生的全基因组直接量化,使用高精度的配对和互补共识测序
Xinyue You1, Yiyi Cao1, Takayoshi Suzuki2
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Nucleic acids research
|October 23, 2023
概括
配对结尾和互补共识测序 (PECC-Seq) 提供了高精度的全基因组体质突变检测. 这种方法可以识别新的DNA病变和人工物,从而能够对体内突变发生和突变性测试进行敏感的量化.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 毒理学 毒理学 毒理学
背景情况:
- 身体突变在癌症等疾病中至关重要.
- 现有的测序方法在精度和灵敏度方面存在局限性.
- 错误纠正下一代测序 (ecNGS) 旨在改善突变检测.
研究的目的:
- 引入配对和互补的共识测序 (PECC-Seq) 以实现高精度的全基因组体质突变检测.
- 为了表征新的DNA病变和NGS图书馆准备文物.
- 应用PECC-Seq来敏感量化体内突变发生和突变性测试.
主要方法:
- 开发和优化PECC-Seq,一个ecNGS方法.
- 2-aminoimidazolone病变和最终修复器件的特征.
- 修改图书馆准备用于酶的工件去除.
- 应用PECC-Seq以量化体内突变发生和确定突变特征.
主要成果:
- 优化的PECC-Seq实现了低于5 × 10−8.8的错误率.
- 该方法准确地检测出低丰度的体质突变.
- 在量化由阿里斯托洛希克酸I (AAI) 诱导的剂量依赖性突变发生时,PECC-Seq显示出高灵敏度.
- 对于各种变异原体,有明显的全基因组突变特征.
结论:
- PECC-Seq是一个强大的工具,用于精确的全基因组体质突变量化.
- 这项技术对敏感的体内致变性检测具有前景.
- 了解DNA病变和文物可以提高测序的准确性.
相关概念视频
Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.


